Morningside Ventures has led a nearly US$10 million series A funding round in TransThera Biosciences Co. Ltd, a Chinese biotech start-up specialized in developing novel new chemical entity drugs. Grand Yangtze Investment, a venture firm based in Shanghai, participated in the round as well. The company, located in the Pharma Valley of Nanjing's High-Tech Zone, […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.